Childhood peanut allergy rates fall sharply

Medical professionals have long advised parents to delay the introduction of peanut products to infants, yet new evidence suggests this caution may have contributed to the condition. A study released in October 2025 indicates that rates of peanut allergy in children under the age of three have declined by roughly 43% over the past ten years.

Dr. David Hill, the lead author of the research, attributes the reversal to a shift in clinical guidance. The study demonstrates that introducing peanut products to infants between four and six months of age reduces the likelihood of developing an allergy. Hill stated, “It’s safe to say in all likelihood, there are tens of thousands of kids today that don’t have food allergy that may have if we hadn’t made these recommendations about early allergen introduction.”

The change in protocol has altered daily life for many households. Kristie Herring, whose son Parker suffers from a severe peanut allergy, described the initial diagnosis as a “total surprise” given their family history. Parker is currently undergoing oral immunotherapy. This treatment involves slowly increasing doses of peanut protein, a process that has allowed him to consume peanut butter again without immediate reaction.

The American Academy of Pediatrics now recommends that all infants without a prior history of reaction begin eating peanut products as soon as they are consuming other solid foods. Pediatricians advise starting with small amounts and providing peanut foods at least twice a week through the first year of life and beyond. Experts stress that whole peanuts should be avoided in infants due to the risk of choking.

While early introduction is a powerful preventive measure, specialists note it is not a guaranteed cure for every child. Food allergy remains a complex condition with multiple contributing factors. For families whose children have already developed an allergy, specialists recommend consulting an allergist to determine appropriate treatment options. Parents are also advised to maintain strict vigilance in managing the condition to prevent severe reactions.

The research provides a clear metric for the impact of the guidance shift. The 43% drop in cases among the youngest children represents a measurable change in the prevalence of the allergy over the last decade. The findings support the current standard of care in pediatric medicine, which prioritizes early exposure over avoidance for most infants.